Literature DB >> 2246515

IgG autoantibody activity in normal mouse serum is controlled by IgM.

M Adib1, J Ragimbeau, S Avrameas, T Ternynck.   

Abstract

In the serum of normal BALB/c mice, IgG antibody reactivity to mouse actin and tubulin, DNA, and TNP groups was very low compared to that of the IgM. This activity was considerably increased when IgG was separated, by affinity chromatography on protein A-Sepharose, whereas no difference in the IgM activity was observed. Addition of IgM to IgG isolated from the same serum resulted in the inhibition of IgG binding to these Ag. Isolation of IgG antibodies on actin, TNP, and tubulin immunoadsorbents has indicated that at least part of the IgG antibodies is polyreactive. In order to understand this inhibition better, experiments with F(ab')2 fragments of IgG were performed. IgM inhibited the binding of F(ab')2 to the antigens in a dose-dependent manner and reacted with immobilized F(ab')2. IgM isolated on F(ab')2 immunoadsorbent, as compared to the initial IgM preparation, were less active toward the Ag but more inhibitory for IgG binding to the Ag. In some pathologic situations, IgM failed to inhibit some IgG antibody activities. The anti-DNA IgG activity from (NZB x NZW)F1 mice was not affected by autologous IgM. Similarly the anti-tubulin IgG from mice infected with Trypanosoma cruzi were less inhibited by IgM from autologous serum than antitubulin IgG from normal mice. These results are compatible with the existence in normal mice of an idiotypic-like network, regulating via an IgM population in the serum, the binding of IgG autoantibodies to self Ag. Modifications of this idiotype-anti-idiotype system might lead to the expression and/or expansion of autoreactive IgG-producing clones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246515

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Diversity of antibody-mediated immunity at the mucosal barrier.

Authors:  J P Bouvet; V A Fischetti
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.

Authors:  T Vassilev; N Mihaylova; E Voynova; M Nikolova; M Kazatchkine; S Kaveri
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals.

Authors:  P Lévy-Soussan; A Berneman; M F Poirier; A Galinowski; H Loo; J P Olié; S Avrameas
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

4.  Isotype and antibody specificity of spontaneously formed immunoglobulins in pig fetuses and germ-free piglets: production by CD5- B cells.

Authors:  B Cukrowska; J Sinkora; Z Reháková; M Sinkora; I Splíchal; L Tucková; S Avrameas; A Saalmüller; R Barot-Ciorbaru; H Tlaskalová-Hogenová
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 5.  Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.

Authors:  N Ronda; S V Kaveri; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Polyreactive IgM antibodies in the circulation are masked by antigen binding.

Authors:  G Sigounas; N Kolaitis; E Monell-Torrens; A L Notkins
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

7.  Immunoregulatory characteristics of the in vitro anti-ssDNA response.

Authors:  C C Anderson; A Panoskaltsis; N R Sinclair
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 8.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

9.  Characterization of the Antibody Response after Cervical Spinal Cord Injury.

Authors:  Antigona Ulndreaj; Apostolia Tzekou; Andrea J Mothe; Ahad M Siddiqui; Rachel Dragas; Charles H Tator; Emina E Torlakovic; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

10.  Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease.

Authors:  M R Grauert; M Houdayer; M Hontebeyrie-Joskowciz
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.